TrialClinical pharmacology in drug development2026

Pharmacokinetics and Safety Evaluation of the Transglutaminase 2 Inhibitor Suvigletistat in Healthy Chinese, Japanese, and White/European Participants.

Romina A Nand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.